Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
Status:
Terminated
Trial end date:
2008-03-05
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe, Asia and South America. A one-year clinical trial to
compare the safety of inhaled human insulin to subcutaneous insulin aspart in subjects with
type 1 or type 2 diabetes and chronic obstructive pulmonary disease (COPD).